Renaissance Capital logo

IKT News

US IPO Week Ahead: Foreign issuers dominate a 4 IPO week

RLX

Four IPOs are scheduled to raise $1.8 billion in the shortened holiday week, featuring a diverse group of foreign issuers.   China’s leading e-cigarette brand RLX Technology (RLX) plans to raise $1.0 billion at a $14.0 billion...read more

Neurodegenerative disease biotech Inhibikase Therapeutics prices IPO at $10 low end

Inhibikase Therapeutics logo

Inhibikase Therapeutics, an early stage biotech developing kinase inhibitors for Parkinson's and related disorders, raised $18 million by offering 1.8 million shares at $10, the low end of the range of $10 to $12. The company originally filed in July 2020 but...read more

US IPO Weekly Recap: Postponements abound as DoorDash joins the IPO pipeline

DASH

Eight SPACs went public this past week but no IPOs, as all three scheduled deals postponed or withdrew. New filing activity picked up, led by long-awaited delivery service unicorn DoorDash (DASH), and several launches indicate increased...read more

Neurodegenerative disease biotech Inhibikase Therapeutics postpones $15 million IPO

Inhibikase Therapeutics logo

Inhibikase Therapeutics, an early stage biotech developing kinase inhibitors for Parkinson's and related disorders, postponed its IPO on Friday. It had planned to raise $15 million by offering 1.4 million shares at a price range of $10 to $12. The Atlanta,...read more